Comparison of febrile morbidity between use and disuse intraoperative topical absorbable hemostatic agents in patient underwent abdominal hysterectomy: a retrospective cohort study
Recruiting
- Conditions
- febrile morbidity between use and disuse intraoperative topical absorbable hemostatic agents in patient underwent abdominal hysterectomyfebrile morbidity, intraoperative topical absorbable hemostatic agents, abdominal hysterectomy
- Registration Number
- TCTR20230910003
- Lead Sponsor
- khonkaen university
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Female
- Target Recruitment
- 316
Inclusion Criteria
All woman who underwent abdominal hysterectomy
Exclusion Criteria
Patients were underlying including chronic inflammation disease, coagulopathy, SLE, HIV, chronic hepatitis and connective tissue disease
Patients were diagnosed prior or during intraoperative infection such as intraabdominal abscess
Patients were used others intraoperative topical absorbable hemostatic agents excepts Surgicel Fibrillar
Patients were not be received appropriate prophylaxis antibiotics
Patient documents were not completely registered information
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method febrile morbidity at early 24 hours after end of the intervention hospital database
- Secondary Outcome Measures
Name Time Method reoperation, vaginal cuff cellulitis and vaginal cuff dehiscence at 30 days after end of the intervention hospital database